HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

DRAPER, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its second quarter of fiscal 2027, before the opening of regular stock market trading on Thursday, August 27, 2026. Following the news release, HealthEquity management will host a conference call for investors on Thursday, August 27, 2026, at 8:30 a.m. Eastern Time to review the Company's second quarter results.

GlobeNewsWire • Aug 3, 2026

HealthEquity (HQY) Upgraded to Buy: What Does It Mean for the Stock?

HealthEquity (HQY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Aug 3, 2026

HealthEquity's Earnings Momentum Deserves More Credit

HealthEquity is the leading HSA and CDB administrator, consistently beating revenue and EPS expectations with strong operational execution. HQY's fiscal 2027 revenue is guided to $1.41–$1.42 billion, with robust HSA asset growth, margin expansion, and accelerating buybacks supporting a Buy rating. Custodial yield remains resilient at 3.84%, supported by rate locks through 2029, while automation and AI investments drive significant cost efficiencies.

Seeking Alpha • Jul 27, 2026

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Jul 23, 2026

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.

Zacks Investment Research • Jul 16, 2026

Here's Why HealthEquity (HQY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Jul 13, 2026

GDRX or HQY: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Jul 8, 2026

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Jul 6, 2026

Is HealthEquity's Improving Profitability Enough to Offset Key Risks?

HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.

Zacks Investment Research • Jun 11, 2026

One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds

Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control

GlobeNewsWire • Jun 8, 2026